Clinical Laserthermia Systems AB (publ) (CLS-B.ST)
SEK 3.84
(-2.04%)
SEK 3.84
(-2.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.27 Million | 6.26 Million | 2.24 Million | 1.33 Million | 1.42 Million | 1.8 Million |
| Cost of Revenue | 5.27 Million | 9.05 Million | 5.87 Million | 456 Thousand | 1.01 Million | 1.29 Million |
| Gross Profit | 2.99 Million | -2.79 Million | -3.63 Million | 876 Thousand | 416 Thousand | 509 Thousand |
| Operating Expenses | 68.93 Million | 64.65 Million | 56.98 Million | 52.68 Million | 42.73 Million | 33.87 Million |
| Selling, General and Administrative Expenses | 68.47 Million | 62.29 Million | 42.63 Million | 40.14 Million | 37.84 Million | 35.74 Million |
| Research and Development Expenses | 2.12 Million | 2.12 Million | 2.1 Million | 2.37 Million | 2.37 Million | 2.01 Million |
| Other Expenses | - | 64.65 Million | 14.34 Million | 12.54 Million | 4.89 Million | -1.87 Million |
| Cost and Expenses | 74.1 Million | 73.7 Million | 62.85 Million | 53.14 Million | 43.74 Million | 35.17 Million |
| Operating Income | -65.93 Million | -67.44 Million | -60.68 Million | -51.81 Million | -42.31 Million | -33.45 Million |
| Interest Expense | 9.76 Million | - | 6.4 Million | 3.27 Million | 1.27 Million | 97.84 Thousand |
| Income Tax Expense | - | -576.11 Thousand | 5.87 Million | 3.27 Million | 1.27 Million | -4000.00 |
| Earnings before Tax | -80.87 Million | -71.26 Million | -64.14 Million | -57.93 Million | -43.37 Million | -32.85 Million |
| Net Income | -79.79 Million | -70.66 Million | -63.61 Million | -57.93 Million | -43.37 Million | -32.85 Million |
| Earnings Per Share Basic | -23.76 | -169.43 | -221.20 | -262.38 | -250.37 | -207.31 |
| Earnings Per Share Diluted | -23.76 | -169.43 | -221.20 | -262.38 | -250.37 | -207.31 |
| Weighted Average Shares Outstanding | 3.35 Million | 417.05 Thousand | 287.59 Thousand | 220.81 Thousand | 173.24 Thousand | 158.48 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 3.35 Million | 417.05 Thousand | 287.59 Thousand | 220.81 Thousand | 173.24 Thousand | 158.48 Thousand |
| Gross Margin | 0.36 | -0.45 | -1.62 | 0.66 | 0.29 | 0.28 |
| EBIT Margin | -8.27 | -9.22 | -24.48 | -38.75 | -27.64 | -18.00 |
| Profit Margin | -9.64 | -11.27 | -28.34 | -43.50 | -30.42 | -18.17 |
| EBITDA | -68.4 Million | -57.84 Million | -57.05 Million | -51.61 Million | -39.41 Million | -32.55 Million |
| Earnings Before Tax Margin | -7.97 | -10.76 | -27.03 | -38.90 | -29.68 | -18.50 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 5.4 Million | 5.62 Million | 3.14 Million | 8.27 Million | 4.45 Million | 1.97 Million |
| Cost of Revenue | 14.7 Million | 2.75 Million | 3.81 Million | 74.1 Million | 24.6 Million | 494 Thousand |
| Gross Profit | -9.29 Million | 2.87 Million | -676 Thousand | -65.83 Million | -20.14 Million | 1.48 Million |
| Operating Expenses | - | 15.74 Million | 16.31 Million | 68.47 Million | 20.23 Million | 17.09 Million |
| Selling, General and Administrative Expenses | - | - | 15.74 Million | - | 19.68 Million | 16.3 Million |
| Research and Development Expenses | - | - | - | - | 2.12 Million | - |
| Other Expenses | - | 15.74 Million | - | - | - | - |
| Cost and Expenses | 14.7 Million | 18.49 Million | 20.13 Million | 74.1 Million | 24.6 Million | 17.59 Million |
| Operating Income | -9.29 Million | -12.87 Million | -16.99 Million | -65.83 Million | -20.14 Million | -15.61 Million |
| Interest Expense | 383 Thousand | 21 Thousand | 9000.00 | 9.76 Million | 58.48 Thousand | 992 Thousand |
| Income Tax Expense | -3.28 Million | -2000.00 | -172 Thousand | -1.08 Million | -398 Thousand | -442 Thousand |
| Earnings before Tax | -12.96 Million | -13.59 Million | -12.57 Million | -80.87 Million | -25.64 Million | -17.24 Million |
| Net Income | -12.96 Million | -13.59 Million | -12.39 Million | -79.79 Million | -25.25 Million | -16.8 Million |
| Earnings Per Share Basic | -0.98 | -0.98 | -1.70 | - | -3.78 | -3.26 |
| Earnings Per Share Diluted | -0.98 | -0.98 | -1.70 | - | -3.78 | -3.26 |
| Weighted Average Shares Outstanding | 13.27 Million | 13.93 Million | 7.27 Million | 3.35 Million | 6.67 Million | 5.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.27 Million | 13.93 Million | 7.27 Million | 3.35 Million | 6.67 Million | 5.14 Million |
| Gross Margin | -1.72 | 0.51 | -0.22 | -7.96 | -4.52 | 0.75 |
| EBIT Margin | -2.21 | -2.18 | -5.22 | - | -4.36 | -7.55 |
| Profit Margin | -2.40 | -2.42 | -3.95 | -9.64 | -5.67 | -8.49 |
| EBITDA | -11.97 Million | -12.26 Million | -16.38 Million | - | -19.41 Million | -14.93 Million |
| Earnings Before Tax Margin | -1.72 | -2.29 | -5.41 | -7.96 | -4.52 | -7.89 |
600771
TRCK
8295
0348
SUDARSCHEM
600516